Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY ; volume:18 ; number:1 ; day:6 ; month:10 ; year:2016 ; pages:1-12 ; date:12.2016
Arthritis Research & Therapy ; 18, Heft 1 (6.10.2016), 1-12, 12.2016
- Creator
-
Boyapati, Anita
- Contributor
-
Msihid, Jérôme
Fiore, Stefano
van Adelsberg, Janet
Graham, Neil M. H.
Hamilton, Jennifer D.
SpringerLink (Online service)
- DOI
-
10.1186/s13075-016-1132-9
- URN
-
urn:nbn:de:1111-2016110610898
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boyapati, Anita
- Msihid, Jérôme
- Fiore, Stefano
- van Adelsberg, Janet
- Graham, Neil M. H.
- Hamilton, Jennifer D.
- SpringerLink (Online service)
Other Objects (12)
Methotrexate
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Methotrexate-Related Pancytopenia: A Case Report
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
Subacute quadriplegic myelopathy following intrathecal methotrexate
Methotrexate
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Methotrexate-Related Pancytopenia: A Case Report
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
Subacute quadriplegic myelopathy following intrathecal methotrexate
Methotrexate
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Methotrexate-Related Pancytopenia: A Case Report
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features